ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Supreme Court to Hear Amgen Challenge to Suit

WASHINGTON--The U.S. Supreme Court said Monday it will consider Amgen Inc.'s (AMGN) challenge to a securities lawsuit alleging the biotech company downplayed safety concerns about two drugs used to treat anemia. The suit, brought by Connecticut pension funds on behalf of purchasers of Amgen stock, alleged the Thousand Oaks, Calif., company repeatedly reassured investors about the safety of anti-anemia drugs Aranesp and Epogen even as clinical trial data raised concerns that the drugs could harm cancer patients who were taking them. Amgen's statements led to inflated share prices, the suit alleged. The lawsuit alleged the misrepresentations took place from April 2004 through May 10, 2007, a day when Amgen's shares dropped more than 9% after a Food and Drug Administration panel expressed concerns about the drugs and recommended new limits on patient use. Amgen is seeking to overturn a lower-court ruling that certified the lawsuit to proceed as a class action. The company said the plaintiffs couldn't show that the alleged misrepresentations had a material effect on the price of Amgen shares. The market had readily available access to the safety information that Amgen allegedly downplayed, the company said. At issue before the Supreme Court is whether securities plaintiffs, before being allowed to proceed with a class action lawsuit, have to demonstrate that a company's alleged misrepresentations materially affected share prices. Amgen argued that companies need to be able to defeat weak lawsuits at early stages of the proceedings. Otherwise, companies will feel financial pressures to settle cases even when they think they have a strong defense, Amgen said. The case is Amgen v. Connecticut Retirement Plans and Trust Funds, 11-1085. The Supreme Court is expected to hear oral arguments in the fall. Write to Brent Kendall at brent.kendall@dowjones.com

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/27/201607:21:00Amgen Receives Positive CHMP Opinion To Extend Indication Of...
05/26/201616:00:00Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed...
05/26/201606:10:34Current Report Filing (8-k)
05/25/201619:08:00Amgen Announces Early Tender Results Of Senior Notes Exchange...
05/25/201616:09:00Amgen Announces Pricing Terms Of Senior Notes Exchange Offers
05/23/201616:40:00Samsung Targets U.S. Drug Market With Remicade Knockoff
05/19/201618:02:00Amgen Announces Voting Results of Annual Meeting of Stockholders
05/19/201616:34:00Amgen Highlights Data To Be Presented At 21st Congress Of The...
05/18/201617:44:00Amgen Researchers Discover Gene Associated With Lower Risk of...
05/18/201617:06:00Bayer to Showcase Latest Oncology Research at ASCO 2016
05/18/201617:05:00Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights...
05/18/201617:00:00Landmark deCODE genetics Study Points to a New Mechanism that...
05/17/201616:00:00Amgen's Breakaway from Cancer® Public Service Announcement Delivers...
05/13/201606:16:35Current Report Filing (8-k)
05/12/201621:14:00Amgen Commences Exchange Offers for Certain Series of Outstanding...
05/12/201603:03:00Theranos Executive to Exit Amid Probes -- WSJ
05/11/201623:10:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes
05/11/201622:15:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes
05/11/201622:10:00Theranos Executive Sunny Balwani to Depart
05/11/201621:49:00Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad